T1	Entity 68 90	mitochondrial diseases
T2	Entity 115 148	a wide range of clinical symptoms
T3	Entity 0 39	Multiple respiratory chain deficiencies
T4	Entity 179 201	consanguineous parents
T5	Cluster3 160 169	a subject
T6	Entity 259 296	Multiple respiratory chain deficiency
T7	Entity 359 398	abnormal assembly of complexes I and IV
T8	Entity 400 427	A microsatellite genotyping
T9	Entity 494 518	chromosome 17q24.2-q25.3
T10	Entity 431 449	the family members
T11	Entity 478 490	homozygosity
T12	Entity 556 561	genes
T13	Entity 574 599	mitochondrial translation
T14	Entity 604 613	sequenced
T15	Cluster2 614 620	MRPL12
T16	Cluster2 631 670	the mitochondrial ribosomal protein L12
T17	Entity 727 753	a highly conserved alanine
T18	Entity 711 717	exon 5
T19	Entity 686 707	a c.542C>T transition
T20	Cluster8 783 796	This mutation
T21	Entity 809 839	a decreased steady-state level
T22	Cluster2 843 857	MRPL12 protein
T23	Entity 889 916	the large ribosomal subunit
T24	Entity 864 883	altered integration
T25	Entity 928 971	an overall mitochondrial translation defect
T26	Entity 988 1013	the subject's fibroblasts
T27	Entity 1059 1090	COXI, COXII and COXIII subunits
T28	Entity 1019 1055	a significant reduction of synthesis
T29	Cluster7 1117 1123	Ala181
T30	Cluster2 1104 1110	MRPL12
T31	Entity 1138 1145	a helix
T32	Entity 1283 1305	the elongation factors
T33	Cluster8 1214 1236	the p.Ala181Val change
T34	Entity 1386 1401	L7/L12 proteins
T35	Cluster2 1552 1573	the mammalian protein
T36	Entity 1446 1457	translation
T37	Cluster8 1482 1501	the mutated version
T38	Cluster3 1511 1522	the subject
T39	Cluster5 1627 1660	the eubacterial L7/L12 equivalent
T40	Cluster5 1720 1753	the eubacterial L7/L12 equivalent
T41	Cluster2 1770 1776	MRPL12
T42	Cluster4 1757 1766	Mutations
T43	Cluster4 1806 1815	Mutations
T44	Entity 1830 1859	universal translation factors
T45	Entity 1871 1897	different OXPHOS complexes
T46	Entity 1170 1197	an interface of interaction
T47	Entity 1259 1277	alter interactions
T48	Entity 310 347	muscle and fibroblasts of the subject
T49	Cluster7 759 781	a valine (p.Ala181Val)
T50	Entity 1335 1378	the eubacterial orthologues of human MRPL12
T51	Entity 208 226	growth retardation
T52	Entity 231 257	neurological deterioration
T53	Entity 1092 1100	Modeling
T54	Entity 1424 1442	a selective effect
T55	Entity 1675 1690	MRPL12 function
T56	Entity 1783 1802	translation defects
T57	Cluster1 150 152	We
T58	Cluster1 601 603	We
T59	Cluster1 528 530	we
T60	Cluster1 539 542	our
T61	Cluster8 686 781	a c.542C>T transition in exon 5 changing a highly conserved alanine into a valine (p.Ala181Val)
